1. Home
  2. ALKS vs GBCI Comparison

ALKS vs GBCI Comparison

Compare ALKS & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • GBCI
  • Stock Information
  • Founded
  • ALKS 1987
  • GBCI 1955
  • Country
  • ALKS Ireland
  • GBCI United States
  • Employees
  • ALKS N/A
  • GBCI N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • GBCI Major Banks
  • Sector
  • ALKS Health Care
  • GBCI Finance
  • Exchange
  • ALKS Nasdaq
  • GBCI Nasdaq
  • Market Cap
  • ALKS 5.1B
  • GBCI 5.1B
  • IPO Year
  • ALKS 1991
  • GBCI N/A
  • Fundamental
  • Price
  • ALKS $29.94
  • GBCI $49.60
  • Analyst Decision
  • ALKS Strong Buy
  • GBCI Buy
  • Analyst Count
  • ALKS 14
  • GBCI 6
  • Target Price
  • ALKS $40.64
  • GBCI $50.50
  • AVG Volume (30 Days)
  • ALKS 1.4M
  • GBCI 739.6K
  • Earning Date
  • ALKS 10-23-2025
  • GBCI 10-23-2025
  • Dividend Yield
  • ALKS N/A
  • GBCI 2.65%
  • EPS Growth
  • ALKS 21.99
  • GBCI 17.64
  • EPS
  • ALKS 2.08
  • GBCI 1.93
  • Revenue
  • ALKS $1,505,296,000.00
  • GBCI $855,046,000.00
  • Revenue This Year
  • ALKS N/A
  • GBCI $16.01
  • Revenue Next Year
  • ALKS $1.66
  • GBCI $25.89
  • P/E Ratio
  • ALKS $14.40
  • GBCI $25.82
  • Revenue Growth
  • ALKS N/A
  • GBCI 11.62
  • 52 Week Low
  • ALKS $25.56
  • GBCI $36.76
  • 52 Week High
  • ALKS $36.45
  • GBCI $60.67
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 59.07
  • GBCI 66.00
  • Support Level
  • ALKS $28.77
  • GBCI $48.16
  • Resistance Level
  • ALKS $31.69
  • GBCI $49.47
  • Average True Range (ATR)
  • ALKS 0.85
  • GBCI 1.07
  • MACD
  • ALKS 0.11
  • GBCI 0.21
  • Stochastic Oscillator
  • ALKS 51.25
  • GBCI 83.87

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About GBCI Glacier Bancorp Inc.

Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.

Share on Social Networks: